HealthLynked
Welcomes Jeremy Daniel as Chief Financial Officer
Naples,
FL -- January 15, 2025 -- InvestorsHub NewsWire -- HealthLynked
Corp. (OTCQB:
HLYK), a
pioneering provider of healthcare technology solutions, is proud to
announce the appointment of Jeremy Daniel as its new Chief
Financial Officer (CFO), effective immediately. With an impressive
career spanning over two decades, Mr. Daniel brings exceptional
expertise in financial management, strategic planning, and
organizational development.
As CFO, Jeremy will
oversee HealthLynked's financial strategy and operations, driving
growth, operational efficiency, and shareholder value. His
appointment underscores HealthLynked's commitment to strengthening
its executive leadership as the company continues to innovate and
expand its healthcare technology solutions.
Jeremy Daniel has built a
stellar reputation as a results-driven executive in diverse
industries including healthcare, biotechnology, and finance. Most
recently, he served as CFO for Innoveren Scientific, a publicly
traded biotech firm, where he successfully led acquisitions,
improved financial systems, and implemented strategic initiatives
that fueled the company's growth and operational success. His
achievements include raising over $100M in funding through public
and private equity markets and executing pivotal mergers and
acquisitions.
Michael Dent, M.D., CEO
of HealthLynked, shared his enthusiasm for the
appointment:
"Jeremy's
extensive experience and proven leadership in financial operations
and strategic planning make him an outstanding addition to the
HealthLynked team. His track record of optimizing financial
performance and supporting organizational growth aligns perfectly
with our vision to revolutionize healthcare through
technology."
On accepting the
position, Mr. Daniel expressed his excitement about the opportunity
to contribute to HealthLynked's mission:
"Joining
HealthLynked at this transformative time is a true honor. I am
excited to leverage my experience to enhance financial strategies,
foster innovation, and support the company's efforts in improving
patient outcomes and healthcare connectivity."
With a career that has
included roles as CFO for Regenerative Medicine Solutions and
controller for Omnicare, Mr. Daniel is well-versed in leading
financial systems in compliance with GAAP and SEC regulations. A
Certified Public Accountant (CPA) and holder of an MBA from Xavier
University, his credentials position him to lead with precision and
integrity.
About
HealthLynked Corp.
HealthLynked is dedicated
to transforming healthcare by leveraging technology to connect
patients and providers. Its cloud-based HealthLynked Network
empowers patients to manage their medical information securely
while enabling providers to optimize care and operations. Through
innovation and collaboration, HealthLynked aims to create a more
efficient and patient-centric healthcare system. For more
information, visit
www.healthlynked.com.
Download the
HealthLynked App
Forward-Looking
Statements
Forward-Looking
Statements in this press release, which are not historical facts,
are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Our actual results,
including as a result of any acquisitions, performance, or
achievements, may differ materially from those expressed or implied
by these forward-looking statements. In some cases, you can
identify forward-looking statements by the use of words such as
"may," "could," "expect," "intend," "plan," "seek," "anticipate,"
"believe," "estimate," "predict," "potential," "continue,"
"likely," "will," "would," and variations of these terms and
similar expressions, or the negative of these terms or similar
expressions. Such forward-looking statements are necessarily based
upon estimates and assumptions that, while considered reasonable by
our management and us, are inherently uncertain. We caution you not
to place undue reliance on any forward-looking statements, which
are made as of the date of this press release. We undertake no
obligation to update publicly any of these forward-looking
statements to reflect actual results, new information, or future
events, changes in assumptions, or changes in other factors
affecting forward-looking statements, except to the extent required
by applicable laws. If we update one or more forward-looking
statements, no inference should be drawn that we will make
additional updates with respect to those or other forward-looking
statements. Certain risks and uncertainties applicable to our
operations and us are described in the "Risk Factors" section of
our most recent Annual Report on Form 10-K and in other filings we
have made with the U.S. Securities and Exchange Commission. These
reports are publicly available at www.sec.gov.
Contact
Information:
Mike Paisan
Director of Investor
Relations
HealthLynked Corp.
1265 Creekside Pkwy,
Suite 301
Naples, Florida
34108
Phone:
1-800-928-7144
Email: IR@healthlynked.com
